Matthias Aizenberg

Imagine a future where a child’s medical treatment is as unique as their fingerprint, crafted precisely to match their genetic makeup, lifestyle, and environment, ensuring the best possible outcome with minimal side effects. This vision is no longer a distant dream but a tangible reality unfolding

Imagine a world where a simple patch on your skin could tell you more about your health than a trip to the doctor’s office, catching early signs of serious conditions like diabetes or cancer before symptoms even appear. This isn’t science fiction—it’s the cutting edge of health technology today.

Imagine a world where healthcare is just a click away, but the system behind it struggles to prove its worth—telehealth leaders face this challenge every day as they strive to balance quality care with operational sustainability. In an era where virtual care has become a vital part of the

Imagine a simple shot, one already familiar to millions for preventing a painful skin condition, holding the power to shield the mind from a devastating disease like dementia—a condition impacting over 55 million people worldwide with no cure in sight. That’s the startling promise emerging from a

Imagine a world where life-altering therapies for genetic disorders, cancer, and infectious diseases are not just a distant dream but a tangible reality, delivered precisely to the cells that need them most. RNA therapeutics hold this transformative promise, yet their potential remains locked

A therapy that should unleash the immune system instead fuels a tumor’s growth, and the only way to see why is to listen to each cell speak for itself; that is the everyday paradox that single-cell RNA sequencing (scRNA-seq) now makes decipherable in real time. In oncology, this shift from average

In this conversation, we explore why metastatic recurrence strikes nearly one in ten adolescents and young adults (AYAs) who initially present with non-metastatic cancers, how statewide data were linked to reveal patterns across tumor types, and what these findings mean for surveillance, equity,

Every three minutes somewhere in the world, a person with type 1 diabetes calculates a dose of insulin and still lives with the nagging reality that even perfect math will not reproduce the split-second precision of native β-cells. Clinicians point to the autoimmune destruction that erased those

A daily habit as ordinary as pouring a third or fourth cup of coffee may have aligned with a five-year edge in biological aging among people living with schizophrenia and mood disorders, hinting that moderation could matter more than any exotic supplement. The notion is surprising because coffee

Glioblastoma care has long run up against a biological wall that blunts even the best therapies, and a new approach that pries open that wall just long enough to let drugs in now looks like a genuine shift rather than a lab curiosity. Patients still face a dire prognosis despite aggressive surgery